KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Fri, June 9, 2023 | 17:49

Korea to foster local bio industry to produce $76.9 bil. by 2030

Korea to foster local bio industry to produce $76.9 bil. by 2030

The Korean government said Wednesday that it will give full support to the local biotechnology industry to raise the sector's production capacity to 100 trillion won ($76.9 billion) by 2030 as part of its plans to become the world-leading biotech economy.

2023-06-07 11:27

Korean bio firms to seek new opportunities at int'l convention in Boston

Korean bio firms to seek new opportunities at int'l convention in Boston

Samsung Biologics, Celltrion and other Korean biotechnology companies are heading to Boston to take part in the BIO International Convention, also known as BIO USA, to promote their technologies and products and to seek new business opportunities at one of the largest exhibitions in the global bio industry, according to the companies, Sunday.

Baek Byung-yeul | 2023-06-04 16:41

Centrum launches new probiotic products in Korea

Centrum launches new probiotic products in Korea

Centrum, a multivitamin brand of global healthcare company Haleon's, will launch three new probiotics products made by its Korean R&D center and produced by its Korean contract manufacturing organization (CMO) partner in order to improve its presence in the country's growing probiotics market, according to the company, Wednesday.

Baek Byung-yeul | 2023-05-31 15:48

Korea to foster biotechnology as new growth engine: finance minister

Korea to foster biotechnology as new growth engine: finance minister

Korea will lift regulations to help biotechnology startups utilize the database of hospitals, and foster the industry as a new growth engine, the finance minister said Wednesday.

2023-05-24 17:18

SK bioscience calls for global cooperation on sharing vaccine manufacturing capacity

SK bioscience calls for global cooperation on sharing vaccine manufacturing capacity

SK bioscience, a pharmaceutical affiliate under Korea's SK Group, said Tuesday it has called for stronger global cooperation to share vaccine manufacturing capabilities with underdeveloped countries for wider access to vaccines in a future pandemic.

2023-05-23 17:15

HLB seeks approval for liver cancer drug with US FDA

HLB seeks approval for liver cancer drug with US FDA

HLB, an international biopharmaceutical company, submitted a new drug application (NDA) for its Rivoceranib liver cancer drug to the U.S. Food and Drug Administration (FDA) on Tuesday. If successful, it would become the first Korean biotechnology company to win a new drug approval in the U.S., the company said Thursday.

Baek Byung-yeul | 2023-05-18 16:27

[INTERVIEW] BioTNS targets overseas diagnosis market with digital PCR

INTERVIEWBioTNS targets overseas diagnosis market with digital PCR

Molecular diagnostics using polymerase chain reaction (PCR) technology has become a popular diagnostic method due to the outbreak of COVID-19.

Baek Byung-yeul | 2023-05-16 08:16

SK bioscience to produce MSD's Ebola vaccine candidate

SK bioscience to produce MSD's Ebola vaccine candidate

SK bioscience, a local vaccine developer and manufacturer, signed a contract manufacturing organization (CMO) agreement with global healthcare company MSD for the production of its next-generation Zaire Ebola vaccine, according to the company, Monday. MSD has been working with Hilleman Laboratories, an international nonprofit research organization, to develop a next-generatio...

Baek Byung-yeul | 2023-05-08 16:53

Samsung chief seeks cooperation with US biotech firms

Samsung chief seeks cooperation with US biotech firms

Samsung Group is seeking to expand cooperation with innovative biotech companies in the United States as Chairman Lee Jae-yong held a series of meetings with the CEOs of bio companies there, Samsung said Sunday. Korea's largest conglomerate added the bio sector as a business that Lee aims to foster as the group's flagship business. Lee also wants to discover new business oppo...

Baek Byung-yeul | 2023-05-07 16:45

SK bioscience to invest $1.8 bil. by 2027 to become top-tier bio firm

SK bioscience to invest $1.8 bil. by 2027 to become top-tier bio firm

SK bioscience, the country's prominent vaccine developer and producer, will invest around 2.4 trillion won ($1.8 billion) over the next five years until 2027 to become a top-tier bio and vaccine powerhouse, its CEO said Friday.

Baek Byung-yeul | 2023-04-28 16:04

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	Gov't to launch intensive crackdown against foreigners committing drug crimes

2	Dog meat traders condemn first lady, animal rights groups' push for ban

3	INTERVIEWSpaceX's Starlink in Kyiv is wake-up call for Seoul

4	Billy Graham Seoul Crusade celebrates 50th anniversary

5	Dollar remittance, foreign exchange rules to be eased

6	Home gardening boom inspires plant adoption, specialized care services for leafy companions

7	Yoon's labor reform drive sputters as umbrella union exits talks

8	Korean businesses seek tougher punishments for industrial espionage

9	Yoon calls for all-out efforts to win chip war

10	Bookstore specializing in film is haven for readers and seaside lovers alike

DARKROOM